Ekso bionics holdings, inc. (EKSO)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Operating activities:
Net loss

-8,115

-12,132

-13,543

-20,732

-25,642

-26,992

-31,838

-31,190

-28,721

-29,122

-25,720

-27,863

-28,121

-23,470

-22,539

-19,246

-19,126

-19,590

-35,100

-17,891

43,882

-33,769

-13,620

-22,268

-81,796

-3,827

0

0

0

-

-

-

-

Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization

607

690

860

1,120

1,334

1,515

1,608

1,770

1,731

1,748

1,788

1,813

1,860

1,855

1,661

1,422

1,173

933

863

831

788

745

661

575

514

469

0

0

0

-

-

-

-

Provision for excess and obsolete inventories

70

66

59

58

80

191

234

230

203

73

0

0

0

-

-

-

-

-

-

-

9

-36

0

0

0

-

-

-

-

-

-

-

-

Changes in allowance for doubtful accounts

-3

52

132

109

21

-50

-114

-59

89

105

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Gain) loss on revaluation of warrant liabilities

10,017

6,376

7,270

2,158

-791

1,063

-1,104

1,392

4,710

3,909

0

0

0

-

-

-

5,490

2,505

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Gain on change in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

Adjustment to record convertible note at fair value

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-799

0

0

0

-

-

-

-

Stock-based compensation expense

2,206

2,255

2,316

2,767

2,612

2,868

2,891

2,603

2,912

2,414

2,324

2,125

1,941

3,121

3,024

3,041

2,956

1,731

1,592

1,241

1,125

1,143

922

913

671

391

0

0

0

-

-

-

-

Amortization of debt discount and accretion of final payment fee

76

92

108

123

138

152

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

36

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount and accretion of final payment fee

-

-

-

-

-

-

-

-

-

179

72

48

24

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-37

-37

-37

-36

-35

-35

-35

-36

0

0

0

-

-

-

-

Amortization of debt discounts

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

208

233

101

229

169

0

0

0

-

-

-

-

Change in fair value of contingent liabilities

-

-

-

-

-

35

154

172

244

213

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock contribution to 401(k) plan

164

142

169

197

211

212

665

627

565

509

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on modification of warrants

0

-257

-257

-257

-257

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized loss on foreign currency transactions

-200

-133

-474

-181

-686

-381

-216

-7

619

500

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on increase in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-1,139

1,599

2,349

1,103

240

850

706

1,381

2,415

1,085

217

745

-986

-140

72

-771

985

577

264

901

-320

1,000

1,255

576

875

-239

0

0

0

-

-

-

-

Inventories

-992

-893

206

1,717

1,523

1,655

2,111

1,458

1,912

2,096

754

47

-464

541

847

1,052

1,414

200

-136

-449

-588

-354

-76

697

601

102

0

0

0

-

-

-

-

Prepaid expenses, operating lease right-of-use assets, and other assets current and noncurrent

-443

-369

-310

-107

-525

-1,046

-1,587

-17

295

862

1,584

-70

-50

60

-153

258

330

91

294

74

43

36

86

-2

99

87

0

0

0

-

-

-

-

Deferred costs of revenue

-

-

-

-

-

-

-

-

-

-

-

-

-209

-4,590

-4,252

-4,391

-3,667

1,022

1,230

1,901

1,819

1,995

1,598

878

667

442

0

0

0

-

-

-

-

Accounts payable

-475

-1,231

-2,078

-112

-919

752

1,885

-41

100

77

-233

130

-754

-818

-962

-405

1,981

1,738

1,071

1,079

419

-716

-378

186

-449

238

0

0

0

-

-

-

-

Accrued and lease liabilities

-931

-1,135

-103

446

312

559

1,159

1,171

1,005

105

-388

-640

-607

1,468

974

1,166

1,483

-493

864

708

88

944

-108

-186

130

26

0

0

0

-

-

-

-

Deferred revenues

0

-

0

0

0

-

544

897

304

284

7

144

-237

-6,943

-6,318

-7,067

-5,642

1,266

1,344

2,150

2,223

2,679

2,162

1,874

1,000

1,164

0

0

0

-

-

-

-

Net loss for the period

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

0

Increase (Decrease) in Accounts Payable and Accrued Liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

Net cash used in operating activities

-12,317

-15,772

-19,431

-19,069

-20,597

-22,165

-22,655

-27,171

-30,717

-31,226

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-30

-30

-30

-11

-11

0

0

0

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-21,230

-

-15,793

-14,864

-13,376

-15,007

-14,597

-12,054

-12,159

-9,063

0

0

0

-

-

-

-

Investing activities:
Note receivable from stockholder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

0

0

-

-

-

-

Acquisition of property and equipment

53

60

140

160

107

131

154

239

349

456

721

747

949

1,096

1,258

1,530

1,496

1,492

1,532

1,371

1,520

1,487

1,246

956

589

379

0

0

0

-

-

-

-

Net cash used in investing activities

-53

-60

-140

-160

-107

-131

-154

-239

-349

-456

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing activities:
Fees paid related to 2015 issuance of convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

173

173

173

173

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock and warrants, net

13,883

21,188

16,810

20,771

11,751

4,446

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

21,961

21,975

21,929

21,955

0

46

27

27

0

0

0

0

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1,496

-

-1,636

-1,371

-1,520

-1,487

-1,142

-956

-589

-379

0

0

0

-

-

-

-

Proceeds from issuance of 2012 Series B convertible bridge notes, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,000

0

0

0

-

-

-

-

Principal payments on note payable

2,375

2,377

2,372

2,365

2,366

2,174

1,593

1,010

431

54

67

61

82

79

78

94

68

60

89

74

75

2,596

3,329

3,475

3,924

1,829

0

0

0

-

-

-

-

Proceeds from exercise of stock options

173

228

228

229

56

1

5

4

22

46

78

95

106

110

219

226

222

225

182

135

110

102

0

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

53

21,464

21,460

21,444

21,412

0

0

0

-

-

-

-

-

-

-

-

Proceeds from Contributions from Affiliates

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

Net cash (used in) provided by financing activities

11,681

19,039

14,666

18,635

9,441

2,273

2,486

30,651

42,167

42,568

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

1

18

27

32

41

0

0

0

Effect of exchange rate changes on cash

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock, net of repurchases and issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

13,908

-

21,491

21,521

21,453

40,879

22,689

23,822

26,870

8,509

0

0

0

-

-

-

-

Effect of exchange rate changes on cash

-

-

-

-

-

-

-121

-52

45

81

155

119

50

80

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash

-

-

-

-

-

-

-20,444

3,189

11,146

10,967

20,639

6,040

-2,888

-2,706

1,562

-11,590

-8,819

-5,638

4,062

5,286

6,557

24,385

6,370

10,158

13,741

-1,312

-1,294

-1,285

-1,261

29

0

0

0

Supplemental disclosure of cash flow activities
Cash paid for interest

-41

23

-77

-37

-5

18

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for income taxes

312

309

465

465

441

457

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

633

0

0

0

-

-

-

-

Cash paid for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25

0

0

0

-

-

-

-

Supplemental disclosure of non-cash activities
Initial recognition of operating lease right-of-use assets

0

1,454

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Initial recognition of operating lease liabilities

0

1,498

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Transfer of inventory to property and equipment

-245

-77

166

317

976

1,118

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Share issuance for common stock contribution to 401(k) plan

155

191

191

191

191

508

508

508

508

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Share issuance in lieu of cash compensation

969

919

980

980

101

291

230

230

190

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equipois sales earn-out

0

22

22

22

22

28

28

28

75

47

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cumulative retrospective adjustment to retained earnings for ASU 2016-09 adoption

-

-

-

-

-

-

-

-

-

171

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of convertible preferred stock to common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

-

-

-

-